Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

LncRNA ZFAS1/miR-589 regulates the PTEN/PI3K/AKT signal pathway in the proliferation, invasion and migration of breast cancer cells
Song Zhang, Jin Wang, Tingjing Yao, et al.
Cytotechnology (2020) Vol. 72, Iss. 3, pp. 415-425
Open Access | Times Cited: 21

Showing 21 citing articles:

Mechanisms of circRNA/lncRNA-miRNA interactions and applications in disease and drug research
Benchi Ma, Shihao Wang, Wenzheng Wu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114672-114672
Open Access | Times Cited: 111
Regulatory role of microRNAs on PTEN signaling
Soudeh Ghafouri‐Fard, Atefe Abak, Hamed Shoorei, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 133, pp. 110986-110986
Open Access | Times Cited: 72
The long non-coding RNA ZFAS1 promotes colorectal cancer progression via miR200b/ZEB1 axis
Islam T. Salman, Ahmed I. Abulsoud, Dina M. Abo‐Elmatty, et al.
Pathology - Research and Practice (2023) Vol. 247, pp. 154567-154567
Closed Access | Times Cited: 30
Long non-coding RNAs as the critical regulators of PI3K/AKT, TGF-β, and MAPK signaling pathways during breast tumor progression
Amirhosein Maharati, Meysam Moghbeli
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 29
Correlation of PTEN signaling pathway and miRNA in breast cancer
Mahya Mohammadi, Ahmad Fazilat, Alireza Soleimani Mamalo, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 15
Long non-coding RNA ZFAS1 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-10a/SKA1 pathway
Dan Dong, Zhongyi Mu, Ning Wei, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 111, pp. 917-925
Open Access | Times Cited: 65
LncRNA ZFAS1 inhibits triple-negative breast cancer by targeting STAT3
Uttam Sharma, Tushar Singh Barwal, Akanksha Khandelwal, et al.
Biochimie (2021) Vol. 182, pp. 99-107
Closed Access | Times Cited: 37
LncRNA ZFAS1: Role in tumorigenesis and other diseases
Soudeh Ghafouri‐Fard, Mohammad Javad Kamali, Atefe Abak, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 142, pp. 111999-111999
Open Access | Times Cited: 31
LncRNAs and PTEN/PI3K signaling: A symphony of regulation in cancer biology
Waleed Hassan Almalki
Pathology - Research and Practice (2023) Vol. 249, pp. 154764-154764
Closed Access | Times Cited: 10
Emerging roles of non-coding RNAs in modulating the PI3K/Akt pathway in cancer
Mehrdad Hashemi, Elaheh Mohandesi Khosroshahi, Saba Asadi, et al.
Non-coding RNA Research (2024) Vol. 10, pp. 1-15
Open Access | Times Cited: 3
lncRNA MPFAST Promotes Proliferation and Fatty Acid Synthesis of Bovine Mammary Epithelial Cell by Sponging miR-103 Regulating PI3K-AKT Pathway
Lihua Liu, Bing Sun, Fan Zhang, et al.
Journal of Agricultural and Food Chemistry (2022) Vol. 70, Iss. 38, pp. 12004-12013
Closed Access | Times Cited: 13
Revisiting the hallmarks of cancer: A new look at long noncoding RNAs in breast cancer
Pablo Igor Ribeiro Franco, José Rodrigues do Carmo Neto, Liliana Borges de Menezes, et al.
Pathology - Research and Practice (2023) Vol. 243, pp. 154381-154381
Closed Access | Times Cited: 6
An update on the molecular mechanisms of ZFAS1 as a prognostic, diagnostic, or therapeutic biomarker in cancers
Mahdieh Mehrab Mohseni, Hedyeh Zamani, Mina Momeni, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Downregulation of lncRNA ZFAS1 inhibits the hallmarks of thyroid carcinoma via the regulation of miR‑302‑3p on cyclin D1
Wenjing Chen, Lili Zhai, Huiming Liu, et al.
Molecular Medicine Reports (2020) Vol. 23, Iss. 1, pp. 1-1
Open Access | Times Cited: 15
LncRNA ZFAS1 regulates ATIC transcription and promotes the proliferation and migration of hepatocellular carcinoma through the PI3K/AKT signaling pathway
Baoyang Luo, Lin Zhuang, Ju Huang, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 7
Open Access | Times Cited: 1
Research Progress of Long Non-coding RNA-ZFAS1 in Malignant Tumors
Xin Liu, Zhong Ma, Xianxu Zhang, et al.
Cell Biochemistry and Biophysics (2024)
Closed Access | Times Cited: 1
lncRNAs’p potential roles in the pathogenesis of cancer via interacting with signaling pathways; special focus on lncRNA-mediated signaling dysregulation in lung cancer
Sulieman Ibrahim Shelash, Ibraheem Abdulnabi Shabeeb, Irfan Ahmad, et al.
Medical Oncology (2024) Vol. 41, Iss. 12
Closed Access | Times Cited: 1
Long non-coding RNAs and their role in breast cancer pathogenesis and drug resistance: Navigating the non-coding landscape review
Tohada M. AL‐Noshokaty, Gharieb S. El‐Sayyad, Rehab Abdelhamid, et al.
Experimental Cell Research (2024) Vol. 444, Iss. 2, pp. 114365-114365
Closed Access | Times Cited: 1
New insights of LncRNAs fingerprints in breast cancer progression: Tumorigenesis, drug resistance, and therapeutic opportunities
Bashdar Mahmud Hussen, Diyar Idris Othman, Snur Rasool Abdullah, et al.
International Journal of Biological Macromolecules (2024) Vol. 287, pp. 138589-138589
Open Access | Times Cited: 1
S-Adenosylmethionine enhances the inhibitory effect of gemcitabine against pancreatic cancer cells via suppression of the EGFR/AKT pathways
Yan Liu, Linxun Liu, Yang Zhang, et al.
Molecular & Cellular Toxicology (2022) Vol. 18, Iss. 4, pp. 499-508
Closed Access | Times Cited: 3
The regulatory role of <i>ZFAS1/</i>miRNAs/mRNAs axis in cancer: a systematic review
Rahul Singh, S. S. Mandal, Adrija Mohanta, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 33, Iss. 3, pp. 591-604
Closed Access
Page 1

Scroll to top